| Ms Jane Davis Burgess, LICSW | |
|
3031 Westminster Rd, Putney, VT 05346 | |
| (802) 257-8687 | |
| (802) 387-2538 |
| Full Name | Ms Jane Davis Burgess |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 3031 Westminster Rd, Putney, Vermont |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770601098 | NPI | - | NPPES |
| 0VN1602 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 0890000515 (Vermont) | Primary |
| 1041C0700X | Social Worker - Clinical | 104994 (Massachusetts) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jane Davis Burgess, LICSW 3031 Westminster Rd, Putney, VT 05346 Ph: (802) 257-8687 | Ms Jane Davis Burgess, LICSW 3031 Westminster Rd, Putney, VT 05346 Ph: (802) 257-8687 |
News Archive
Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) announced today that the United States Patent and Trademark Office (USPTO) has allowed an Isis patent application that further expands the scope of the "Crooke" patent estate. The newly allowed patent broadly covers methods of cleaving a target RNA via a double-stranded ribonuclease mechanism, including the RNAi mechanism, with chemically modified, single-stranded RNA-containing drugs.
Scientists using advanced genomic analysis technologies from Life Technologies Corporation have sequenced an individual's genome and identified the specific causative mutation associated with Charcot-Marie-Tooth Disease (CMT), one of the most common inherited neurological disorders currently affecting 1 in 2,500 individuals in the United States.
Pregnant women who perceive having had a well-balanced relationship with their parents during their childhood will experience fewer difficulties in the transition to motherhood, as opposed to women whose relationship with their parents was characterized by unresolved anger or rejection - reveals a new study conducted at the University of Haifa.
Patients with diabetic macular oedema benefit from intravitreal dexamethasone implants, a study shows, with the treatment improving best-corrected visual acuity with an acceptable safety profile.
› Verified 8 days ago
Ms. Mareka Ohlson, CSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 126 Main St, Putney, VT 05346 Phone: 802-387-5060 | |
Ms. Linda Dearstyne, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 60 Fort Hill Rd, Putney, VT 05346 Phone: 802-387-4281 | |
Ms. Anne Marie Briccetti, M.S.W. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 63 Main St, Putney, VT 05346 Phone: 802-387-6689 |